04:26 PM EDT, 04/15/2024 (MT Newswires) -- Jean Jacques Bienaime, Director, on April 11, 2024, sold 40,000 shares in Biomarin Pharmaceutical ( BMRN ) for $3,645,000. Following the Form 4 filing with the SEC, Bienaime has control over a total of 722,527 shares of the company, with 474,994 shares held directly and 247,533 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048477/000104847724000063/xslF345X03/wk-form4_1713212473.xml